Hello everyone, I was diagnosed in May 2021 at 50 years old. PSA 426/Gleason 8. Had been on Abiraterone Acetate (AA) along with Lupron and Prednisone. My PSA dropped to 0.1 until recently I became castrate resistant.
I was advised by my team at MD Anderson that my cancer was a strong variant type. Three weeks ago I volunteered to participate in the 2020-0200 Phase II Trial which includes a combination of the following meds.
Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer.
I'm curious if anyone has knowledge of this trial, is also taking part in this trial or took part in Phase I.
Aside from the trial combination of meds, I still continue on Lupron and Prednisone.
Thanks in advance for any replies or feedback.